"Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-CD44 Bispecific Antibody (Single-chain Diabody) is designed to be expressed as one polypeptide chain with four variable domains from two parental antibodies. The middle linker is long enough to form scFv dimers between the two diabody chains. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy. https://www.creative-biolabs.com/bsab/symbolsearch-b%2520cell%2520lymphoma%252038c13%2520idiotype%2520%2526%2520cd44.htm"

Your Trusted Partner to Advance Your Biological Therapeutics Discovery and Development

Antibody Therapy
Recombinant Antibodies
Bispecific Antibodies (BsAbs)
Antibody-Drug Conjugates (ADCs)
Single Domain Antibodies (SdAbs)
De Novo Antibody Discovery
De Novo Antibody Engineering

Cellular Therapy
Chimeric Antigen Receptor (CAR) Therapy Discovery and Development
Stem Cell Therapy Discovery and Development

Gene Therapy
Oncolytic Virus Discovery and Development
mRNA Discovery and Development
Viral Vector Discovery and Development
RNAi Therapeutics Discovery and Development
Formulation & Delivery Discovery and Development

Excellence in Custom Biotechnology and Pharmaceutical Services

Phage Display & Antibody Library Services
Premade Antibody & Peptide Library Services
Preclinical Animal Model Efficacy Services
PK/PD/Toxicity Evaluation Services
Non-Human Primate (NHP) Biologicals
Membrane Protein Drug Discovery Services